It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: pexx421
See, and this is why pharma should not be able to patent meds. Especially meds that are often researched in schools and funded by us taxpayers. Like wth is up with $300 insulin? It literally takes cents to make, and was given away free by the creators. What utter bs. There is one reason meds cost so much, and it’s the same it’s always been. Greed.
originally posted by: peck420
originally posted by: toolgal462
I did NOT get that story from the media, I got it from my friend first hand. Get a life.
If you can't actually argue without making up your own facts - well then you must be a Leftie.
Geesus it's annoying.
As opposed to making retarded claims about systems you have no actual knowledge about?
originally posted by: toolgal462
But the way you are acting leads me to believe you are filled with anger and rage. I will venture a guess that you also suffer from TDS?
The United States currently ranks highest in health care spending among the developed nations of the world. According to data released by the Organization for Economic Co-operation and Development (OECD) in 2018 (the latest for which figures were available), the U.S. rate was a staggering $10,000 per capita. Luxembourg had the second-highest health care budget, with expenditures at $8,000 per capita; Switzerland and Norway round out the top three, spending $7,000 per capita each.
Healthcare spending is a critical expense for most nations and their citizens in order to stay healthy and cared for.
The U.S. continues to spend the most on healthcare per person, even though health outcomes and quality of care is not often ranked highest.
Many European countries follow the U.S. in healthcare spending, but the big difference is most of that cost is subsidized by the government while the U.S. relies on costly, private health insurance plans.
We also pay way more for drugs because we pay for the R&D and other countries don't. They just let us fund it all by paying higher prices
There are essentially no regulations governing how drugs are priced. Instead, pharmaceutical companies select a price based on a drug’s estimated value, which typically translates into what they “believe the market will bear,” said Dr. Aaron Kesselheim, an associate professor of medicine at Harvard Medical School.
there are essentially no regulations governing how drugs are priced. Instead, pharmaceutical companies select a price based on a drug’s estimated value, which typically translates into what they “believe the market will bear,” said Dr. Aaron Kesselheim, an associate professor of medicine at Harvard Medical School. Blockbuster first-in-class treatments, therefore, command stratospheric prices. When Gilead Sciences received Food and Drug Administration (FDA) approval for its hepatitis medication Sovaldi in 2013, the company priced it at $1,000 a pill, or $84,000 for the full course of treatment. The price was possible because the drug worked and, for a time, was the most convenient and effective treatment on the market.
For drugs entering a crowded disease category with multiple other options, the calculus is different. In such cases, a new treatment will typically be priced similarly to its competitors.
The dollar amount a manufacturer assigns a drug is the list price, and functions “like a sticker price on a car,” said Mello. The pharmaceutical company will, depending on the drug and buyer, provide a variety of discounts off the list price.
How such discounts are negotiated is proprietary, carefully guarded by the system’s various players.
Of course everyone can see that the US pumps out a lot of medical research. We are all grateful for that.
The US also has a large and rather wealthy population as well. We cannot expect a small country like Sweden or Australia to be able to complete on the basis of sheer volume of research.
But if you normalize for population, a slightly different picture emerges.